Vanguard Group Inc

Holdings History for Zentalis Pharmaceuticals, Inc. - COMMON-STOCK (ZNTL)

Symbol
ZNTL on Nasdaq
Investment type
Equity / COMMON-STOCK
Latest Disclosed Ownership
3.27M shares
Security Ownership
4.59%
Shares, Excluding Options vs Price
Value, Excluding Options

The Vanguard Group ownership in Zentalis Pharmaceuticals, Inc. COMMON-STOCK (ZNTL)

2025-01-31 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.27M shares of Zentalis Pharmaceuticals, Inc. COMMON-STOCK (ZNTL). This represents 4.59% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.